Herein, our findings showed that SGOL2, which expressed differently between prostate cancer tissue and para-cancer tissue, was positively associated with clinical stage, histopathological grade, lymphatic metastasis, and survival prognosis. This evidence concerns the gene SGO2 and prostate cancer.